"Farm to Pharma": MMJ Bioscience Inc. and ASX-Listed PhytoTech to Merge

Creating the First Global, Vertically-Integrated Medical Cannabis ("MC") Company


  1. PhytoTech Medical Limited (PYL) to merge with MMJ Bioscience Inc. (MMJ) to create a multinational vertically integrated Medical Cannabis (MC) company
  2. A "merger of equals" that strategically positions PYL and MMJ as a diversified, global, growth-oriented and vertically-integrated MC company, from cultivation of medical cannabis to development and distribution of pharmaceutical and nutraceutical products
  3. MMJ-PYL's "Farm to Pharma" strategy diversifies the merged group across all key segments of the MC value chain
  4. Deal consideration (based on PYL's last traded share price of $0.305) of $15.5 million in PYL scrip and an additional $5.185 million in performance shares subject to completion of value creating milestones
  5. Complementary strategies and asset portfolios to yield significant synergies
  6. Revenue from sales of a proprietary GMP-produced gastro-resistant Cannabidiol (CBD) pill expected by July 2015
  7. Near-term license approval for MMJ's Duncan Facility (near Vancouver, BC) under
  8. ...
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.